| Name | 7-chloro-2-(3-methylimidazol-4-yl)thieno[3,2-b]pyridine |
|---|
| Molecular Formula | C11H8ClN3S |
|---|---|
| Molecular Weight | 249.71900 |
| Exact Mass | 249.01300 |
| PSA | 58.95000 |
| LogP | 3.35020 |
|
~81%
225385-09-1 |
| Literature: Methylgene, Inc. Patent: US2007/4675 A1, 2007 ; Location in patent: Page/Page column 63 ; US 20070004675 A1 |
|
~84%
225385-09-1 |
| Literature: Pfizer Inc. Patent: US6492383 B1, 2002 ; |
|
~68%
225385-09-1 |
| Literature: Ragan; Raggon; Hill; Jones; McDermott; Munchhof; Marx; Casavant; Cooper; Doty; Lu Organic Process Research and Development, 2003 , vol. 7, # 5 p. 676 - 683 |
|
~%
225385-09-1 |
| Literature: Ragan; Raggon; Hill; Jones; McDermott; Munchhof; Marx; Casavant; Cooper; Doty; Lu Organic Process Research and Development, 2003 , vol. 7, # 5 p. 676 - 683 |
|
~%
225385-09-1 |
| Literature: Ragan; Raggon; Hill; Jones; McDermott; Munchhof; Marx; Casavant; Cooper; Doty; Lu Organic Process Research and Development, 2003 , vol. 7, # 5 p. 676 - 683 |
|
~%
225385-09-1 |
| Literature: Ragan; Raggon; Hill; Jones; McDermott; Munchhof; Marx; Casavant; Cooper; Doty; Lu Organic Process Research and Development, 2003 , vol. 7, # 5 p. 676 - 683 |
| Precursor 7 | |
|---|---|
| DownStream 0 | |